SEC Filing Timeline
8-KSep 08, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KSep 04, 2026
Material agreement · Items 1.01,2.03,7.01,9.01
10-QAug 06, 2026
Quarterly report
8-KAug 06, 2026
Earnings release · Items 2.02,9.01
8-KJun 15, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KJun 10, 2026
Shareholder vote results · Items 5.07
10-QMay 11, 2026
Quarterly report
8-KMay 11, 2026
Earnings release · Items 2.02,9.01
8-KApr 30, 2026
Material agreement · Items 1.01,2.02,9.01
DEFA14AApr 30, 2026
Additional proxy
DEF 14AApr 30, 2026
Proxy statement
424B5Apr 29, 2026
Prospectus / offering
424B5Apr 27, 2026
Prospectus / offering
8-KApr 27, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
Recent News (Finnhub)
Nike downgraded, Home Depot initiated: Wall Street's top analyst calls
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
Barclays Initiates Coverage On Intellia Therapeutics with Underweight Rating, Announces Price Target of $8
Intellia Therapeutics Q2 2026 Earnings Call Transcript
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
Could This Cathie Wood Stock Soar in 2027?